Starting Semaglutide in Houston: 5-Step Prep Checklist

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed to treat type 2 diabetes. It works by mimicking the GLP-1 hormone, slowing gastric emptying, reducing appetite, and improving blood sugar regulation. For weight management, the landmark STEP (Semaglutide Treatment Effect in People with Obesity) trial program is the gold standard of evidence. In the STEP 1 trial (published in the New England Journal of Medicine, 2021), adults with obesity who took 2.4 mg subcutaneous semaglutide weekly lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group. STEP 2 demonstrated meaningful weight loss in patients with type 2 diabetes (9.6%), and STEP 3 showed even greater results (16%) when combined with intensive behavioral counseling. these results were achieved in controlled clinical trial settings alongside lifestyle interventions, meaning diet, exercise, and behavior change remain essential components of any semaglutide-based treatment plan. Your Houston physician will help contextualize these numbers for your individual health profile.

Not every patient is an appropriate candidate for semaglutide. The FDA approved Wegovy® (semaglutide 2.4 mg) for adults with a BMI ≥30, or ≥27 with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia. Houston is particularly relevant here: the Houston metro area has obesity rates consistently above the national average, and Harris County data shows disproportionately high rates of type 2 diabetes and cardiovascular disease, conditions that often qualify patients for GLP-1 therapy. Before prescribing, your physician will screen for contraindications, including a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), pancreatitis, or severe gastrointestinal disease. Patients who are pregnant or planning to become pregnant should not use semaglutide. Bring a complete list of your current medications, including supplements, to your first appointment, as drug interactions with insulin and sulfonylureas require careful management. Houston-area internists and obesity medicine specialists are well-versed in these evaluations.

Semaglutide must be prescribed and monitored by a licensed physician or qualified healthcare provider, never sourced from unregulated online pharmacies or medical spas that lack proper oversight. Greater Houston gives you access to board-certified obesity medicine physicians, endocrinologists, and internal medicine doctors across every major suburb. That's a real advantage. Use it carefully.

When you're evaluating a clinic, prioritize providers certified by the American Board of Obesity Medicine (ABOM) or the American Board of Internal Medicine with an endocrinology subspecialty. Certification tells you the physician has met a defined clinical standard, not just completed a weekend course.

Before any prescription is written, the clinic should run baseline labs: a metabolic panel, HbA1c, lipid panel, and thyroid function tests. Ask for this directly. If a clinic hesitates or skips this step, walk out.

The Woodlands and Katy clinics frequently offer same-week new patient appointments and telehealth follow-ups, a practical option if your work schedule or Houston commute makes repeated in-person visits difficult. In Sugar Land and Pearland, several multi-specialty practices pair obesity medicine with cardiology and endocrinology under one roof, so co-management happens without you coordinating between separate offices.

Refuse any provider who prescribes semaglutide without an in-person or synchronous telehealth evaluation, a thorough medical history review, and a clear plan for routine follow-up visits. No exceptions.

Baseline labs come before your first injection, not after. Your prescribing physician should order a complete metabolic panel (CMP) to check kidney and liver function, a hemoglobin A1c (HbA1c) for blood sugar control, a fasting lipid panel, a thyroid-stimulating hormone (TSH) test to rule out thyroid disorders, and a complete blood count (CBC). Those five are standard. If you have a history of pancreatitis or current symptoms, expect serum amylase and lipase on that list too.

These labs serve three purposes: establish your health baseline, catch contraindications early, and give your physician measurable benchmarks for tracking your progress on semaglutide.

If your employer-sponsored plan runs through Blue Cross Blue Shield of Texas, UnitedHealthcare, or Aetna, these labs may fall under your preventive care or chronic disease management benefits. Call your insurer before your appointment to confirm coverage. Don't assume.

Quest Diagnostics and LabCorp both have draw sites across Harris, Fort Bend, and Montgomery counties, so completing labs quickly is straightforward once your physician submits the order.

Bring every prior medical record to your consultation. Cardiac workups especially. Your physician needs the full picture before writing your first prescription.

Cost is one of the most common barriers Houston patients face when pursuing semaglutide treatment. Wegovy® has a list price of approximately $1,349 per month without insurance, though actual out-of-pocket costs vary significantly. In Texas, insurance coverage for GLP-1 weight loss medications remains inconsistent. Major Texas carriers including Blue Cross Blue Shield of Texas (BCBSTX), UnitedHealthcare, Cigna, and Aetna may cover Wegovy® under certain pharmacy benefit plans, but most require prior authorization (PA). To obtain PA, your physician will typically need to document a qualifying BMI, one or more comorbidities, evidence of prior weight loss attempts, and confirmation that the medication is medically necessary. Texas Medicaid (STAR/CHIP programs) does not currently cover Wegovy® for obesity treatment, though coverage for Ozempic® in type 2 diabetes patients may apply. If you receive insurance through a large Houston-area employer, such as the Texas Medical Center, Houston ISD, or a major energy company, check whether your plan includes an obesity benefit rider, as some employer-sponsored plans have expanded GLP-1 coverage in recent years. Your clinic's prior authorization team can assist with documentation.

If insurance does not cover semaglutide, Houston patients have several legitimate cost-reduction options to explore. Novo Nordisk, the manufacturer of Wegovy® and Ozempic®, offers the Novo Nordisk Patient Assistance Program (NovoCare®), which can provide the medication at no cost or reduced cost for qualifying low-income patients. a Wegovy® savings card is available for commercially insured patients, potentially reducing monthly costs to as low as $25 for eligible individuals, visit NovoNordisk's official website or ask your clinic's financial counselor for enrollment details. For patients who do not qualify for these programs, some Houston-area physician-supervised clinics offer bundled treatment packages that include office visits, labs, and medication at a transparent monthly rate, typically ranging from $250-$500/month depending on the practice and services included. Compounded semaglutide from state-licensed 503B pharmacies was available as an FDA enforcement discretion option during the drug shortage period; however, patients should confirm the current regulatory status with their physician, as FDA enforcement policies on compounded GLP-1s have evolved. Never purchase semaglutide from unverified online sources.

Semaglutide treatment follows a structured dose escalation schedule designed to minimize gastrointestinal side effects. For Wegovy®, the protocol begins at 0.25 mg subcutaneously once weekly for four weeks, escalating every four weeks through 0.5 mg, 1.0 mg, 1.7 mg, before reaching the maintenance dose of 2.4 mg at week 17. This gradual titration is critical, do not skip ahead. The most commonly reported side effects in the STEP trials were gastrointestinal in nature: nausea (44% of participants), diarrhea (30%), vomiting (24%), and constipation (24%). Most of these symptoms were mild to moderate and tended to peak during dose increases before subsiding. Houston patients starting treatment in the summer months should be particularly attentive to hydration, as nausea combined with Texas heat can increase the risk of dehydration. Your physician may recommend eating smaller meals, avoiding high-fat foods during the initial weeks, and taking the injection on a consistent day each week. Report any severe abdominal pain, persistent vomiting, or signs of an allergic reaction to your provider immediately. Regular monthly follow-up appointments, either in-person or via telehealth, are essential during this phase.

The STEP 3 trial found that semaglutide paired with intensive behavioral therapy produced an average 16% weight loss, more than medication alone. That gap matters. GLP-1 therapy works best when it's part of a structured lifestyle program, not a standalone fix.

The Texas Medical Center's Ben Taub and UTHealth Houston clinics both run formal obesity medicine programs with registered dietitian access built in. If you need a supervised fitness program, YMCAs in Katy, Sugar Land, and The Woodlands offer options specifically designed for patients carrying obesity-related comorbidities.

Semaglutide suppresses appetite significantly. That's useful for weight loss, but it also means you may not feel hungry enough to hit your protein targets. Most protocols call for 1.2-1.6 g of protein per kilogram of body weight daily. An RD who has worked with GLP-1 patients understands this problem and can help you eat enough of the right things even when food sounds unappealing.

Houston's restaurant culture actually works in your favor here. Mediterranean, Asian, and Latin cuisines are widely available across the city and naturally lean toward lean proteins and vegetables, the exact foods that support a nutrient-dense eating pattern on a reduced appetite.

Emotional eating doesn't disappear because a drug curbs hunger. Several Houston-area psychology practices specialize in health behavior change and offer cognitive behavioral therapy and mindfulness-based programs targeting exactly this issue.